Logo image of HOLX

HOLOGIC INC (HOLX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:HOLX - US4364401012 - Common Stock

74.95 USD
+0.01 (+0.01%)
Last: 12/19/2025, 8:00:02 PM
74.95 USD
0 (0%)
After Hours: 12/19/2025, 8:00:02 PM
Fundamental Rating

6

HOLX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making HOLX a very profitable company, without any liquidiy or solvency issues. HOLX is not valued too expensively and it also shows a decent growth rate. With these ratings, HOLX could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

HOLX had positive earnings in the past year.
In the past year HOLX had a positive cash flow from operations.
Each year in the past 5 years HOLX has been profitable.
HOLX had a positive operating cash flow in each of the past 5 years.
HOLX Yearly Net Income VS EBIT VS OCF VS FCFHOLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

1.2 Ratios

HOLX has a better Return On Assets (6.28%) than 85.03% of its industry peers.
The Return On Equity of HOLX (11.21%) is better than 87.70% of its industry peers.
Looking at the Return On Invested Capital, with a value of 11.59%, HOLX belongs to the top of the industry, outperforming 91.44% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for HOLX is in line with the industry average of 8.80%.
The last Return On Invested Capital (11.59%) for HOLX is above the 3 year average (10.78%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.28%
ROE 11.21%
ROIC 11.59%
ROA(3y)6.63%
ROA(5y)11.04%
ROE(3y)11.9%
ROE(5y)21.35%
ROIC(3y)10.78%
ROIC(5y)15.7%
HOLX Yearly ROA, ROE, ROICHOLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

1.3 Margins

With an excellent Profit Margin value of 13.80%, HOLX belongs to the best of the industry, outperforming 90.37% of the companies in the same industry.
In the last couple of years the Profit Margin of HOLX has declined.
Looking at the Operating Margin, with a value of 26.06%, HOLX belongs to the top of the industry, outperforming 95.72% of the companies in the same industry.
In the last couple of years the Operating Margin of HOLX has declined.
HOLX has a Gross Margin of 56.35%. This is comparable to the rest of the industry: HOLX outperforms 54.55% of its industry peers.
In the last couple of years the Gross Margin of HOLX has remained more or less at the same level.
Industry RankSector Rank
OM 26.06%
PM (TTM) 13.8%
GM 56.35%
OM growth 3Y-8.39%
OM growth 5Y-3.08%
PM growth 3Y-19.83%
PM growth 5Y-14.12%
GM growth 3Y-3.13%
GM growth 5Y-1.14%
HOLX Yearly Profit, Operating, Gross MarginsHOLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so HOLX is still creating some value.
The number of shares outstanding for HOLX has been reduced compared to 1 year ago.
HOLX has less shares outstanding than it did 5 years ago.
HOLX has a worse debt/assets ratio than last year.
HOLX Yearly Shares OutstandingHOLX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
HOLX Yearly Total Debt VS Total AssetsHOLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

HOLX has an Altman-Z score of 4.26. This indicates that HOLX is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 4.26, HOLX is doing good in the industry, outperforming 75.94% of the companies in the same industry.
The Debt to FCF ratio of HOLX is 2.79, which is a good value as it means it would take HOLX, 2.79 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.79, HOLX belongs to the top of the industry, outperforming 85.03% of the companies in the same industry.
HOLX has a Debt/Equity ratio of 0.50. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.50, HOLX is in line with its industry, outperforming 41.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 2.79
Altman-Z 4.26
ROIC/WACC1.42
WACC8.15%
HOLX Yearly LT Debt VS Equity VS FCFHOLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 3.75 indicates that HOLX has no problem at all paying its short term obligations.
HOLX has a Current ratio of 3.75. This is in the better half of the industry: HOLX outperforms 65.78% of its industry peers.
HOLX has a Quick Ratio of 3.06. This indicates that HOLX is financially healthy and has no problem in meeting its short term obligations.
HOLX's Quick ratio of 3.06 is fine compared to the rest of the industry. HOLX outperforms 66.84% of its industry peers.
Industry RankSector Rank
Current Ratio 3.75
Quick Ratio 3.06
HOLX Yearly Current Assets VS Current LiabilitesHOLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

5

3. Growth

3.1 Past

HOLX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.66%.
HOLX shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.31% yearly.
The Revenue has been growing slightly by 1.74% in the past year.
HOLX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.66% yearly.
EPS 1Y (TTM)4.66%
EPS 3Y-10.77%
EPS 5Y1.31%
EPS Q2Q%11.88%
Revenue 1Y (TTM)1.74%
Revenue growth 3Y-5.53%
Revenue growth 5Y1.66%
Sales Q2Q%6.24%

3.2 Future

HOLX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.79% yearly.
Based on estimates for the next years, HOLX will show a small growth in Revenue. The Revenue will grow by 4.75% on average per year.
EPS Next Y8.71%
EPS Next 2Y9.36%
EPS Next 3Y9.26%
EPS Next 5Y8.79%
Revenue Next Year4.99%
Revenue Next 2Y5.36%
Revenue Next 3Y5.4%
Revenue Next 5Y4.75%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HOLX Yearly Revenue VS EstimatesHOLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
HOLX Yearly EPS VS EstimatesHOLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2 4 6 8

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 17.55, HOLX is valued on the expensive side.
83.42% of the companies in the same industry are more expensive than HOLX, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of HOLX to the average of the S&P500 Index (26.38), we can say HOLX is valued slightly cheaper.
With a Price/Forward Earnings ratio of 16.15, HOLX is valued correctly.
Based on the Price/Forward Earnings ratio, HOLX is valued cheaper than 86.10% of the companies in the same industry.
HOLX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.83.
Industry RankSector Rank
PE 17.55
Fwd PE 16.15
HOLX Price Earnings VS Forward Price EarningsHOLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HOLX indicates a rather cheap valuation: HOLX is cheaper than 86.63% of the companies listed in the same industry.
HOLX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HOLX is cheaper than 90.37% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.47
EV/EBITDA 12.26
HOLX Per share dataHOLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of HOLX may justify a higher PE ratio.
PEG (NY)2.02
PEG (5Y)13.35
EPS Next 2Y9.36%
EPS Next 3Y9.26%

0

5. Dividend

5.1 Amount

HOLX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

HOLOGIC INC

NASDAQ:HOLX (12/19/2025, 8:00:02 PM)

After market: 74.95 0 (0%)

74.95

+0.01 (+0.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)02-03 2026-02-03/amc
Inst Owners99.88%
Inst Owner Change-2.26%
Ins Owners0.95%
Ins Owner Change9.34%
Market Cap16.71B
Revenue(TTM)4.10B
Net Income(TTM)565.70M
Analysts68
Price Target76.86 (2.55%)
Short Float %1.96%
Short Ratio1.21
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.71%
Min EPS beat(2)0.67%
Max EPS beat(2)0.76%
EPS beat(4)2
Avg EPS beat(4)0.05%
Min EPS beat(4)-0.63%
Max EPS beat(4)0.76%
EPS beat(8)5
Avg EPS beat(8)0.57%
EPS beat(12)9
Avg EPS beat(12)3.66%
EPS beat(16)13
Avg EPS beat(16)12.29%
Revenue beat(2)0
Avg Revenue beat(2)-0.37%
Min Revenue beat(2)-0.52%
Max Revenue beat(2)-0.21%
Revenue beat(4)0
Avg Revenue beat(4)-1.1%
Min Revenue beat(4)-2.22%
Max Revenue beat(4)-0.21%
Revenue beat(8)1
Avg Revenue beat(8)-0.72%
Revenue beat(12)4
Avg Revenue beat(12)0.24%
Revenue beat(16)8
Avg Revenue beat(16)3.17%
PT rev (1m)1.54%
PT rev (3m)3.22%
EPS NQ rev (1m)0.75%
EPS NQ rev (3m)0.38%
EPS NY rev (1m)0.74%
EPS NY rev (3m)0.62%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)0.28%
Revenue NY rev (1m)0.44%
Revenue NY rev (3m)0.53%
Valuation
Industry RankSector Rank
PE 17.55
Fwd PE 16.15
P/S 4.07
P/FCF 18.47
P/OCF 15.8
P/B 3.31
P/tB 20.42
EV/EBITDA 12.26
EPS(TTM)4.27
EY5.7%
EPS(NY)4.64
Fwd EY6.19%
FCF(TTM)4.06
FCFY5.42%
OCF(TTM)4.74
OCFY6.33%
SpS18.4
BVpS22.65
TBVpS3.67
PEG (NY)2.02
PEG (5Y)13.35
Graham Number46.64
Profitability
Industry RankSector Rank
ROA 6.28%
ROE 11.21%
ROCE 13.29%
ROIC 11.59%
ROICexc 15.96%
ROICexgc 58.01%
OM 26.06%
PM (TTM) 13.8%
GM 56.35%
FCFM 22.06%
ROA(3y)6.63%
ROA(5y)11.04%
ROE(3y)11.9%
ROE(5y)21.35%
ROIC(3y)10.78%
ROIC(5y)15.7%
ROICexc(3y)15.44%
ROICexc(5y)20.96%
ROICexgc(3y)64.46%
ROICexgc(5y)90.41%
ROCE(3y)12.37%
ROCE(5y)18.01%
ROICexgc growth 3Y-19.85%
ROICexgc growth 5Y-5.68%
ROICexc growth 3Y-13.66%
ROICexc growth 5Y-3.5%
OM growth 3Y-8.39%
OM growth 5Y-3.08%
PM growth 3Y-19.83%
PM growth 5Y-14.12%
GM growth 3Y-3.13%
GM growth 5Y-1.14%
F-Score7
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 2.79
Debt/EBITDA 1.84
Cap/Depr 50.83%
Cap/Sales 3.72%
Interest Coverage 9.46
Cash Conversion 77.26%
Profit Quality 159.93%
Current Ratio 3.75
Quick Ratio 3.06
Altman-Z 4.26
F-Score7
WACC8.15%
ROIC/WACC1.42
Cap/Depr(3y)47.55%
Cap/Depr(5y)42.44%
Cap/Sales(3y)3.64%
Cap/Sales(5y)3.29%
Profit Quality(3y)167.51%
Profit Quality(5y)154.37%
High Growth Momentum
Growth
EPS 1Y (TTM)4.66%
EPS 3Y-10.77%
EPS 5Y1.31%
EPS Q2Q%11.88%
EPS Next Y8.71%
EPS Next 2Y9.36%
EPS Next 3Y9.26%
EPS Next 5Y8.79%
Revenue 1Y (TTM)1.74%
Revenue growth 3Y-5.53%
Revenue growth 5Y1.66%
Sales Q2Q%6.24%
Revenue Next Year4.99%
Revenue Next 2Y5.36%
Revenue Next 3Y5.4%
Revenue Next 5Y4.75%
EBIT growth 1Y10.13%
EBIT growth 3Y-13.45%
EBIT growth 5Y-1.47%
EBIT Next Year21.37%
EBIT Next 3Y11.06%
EBIT Next 5Y10.17%
FCF growth 1Y-20.99%
FCF growth 3Y-23.22%
FCF growth 5Y4.1%
OCF growth 1Y-17.75%
OCF growth 3Y-20.77%
OCF growth 5Y3.35%

HOLOGIC INC / HOLX FAQ

Can you provide the ChartMill fundamental rating for HOLOGIC INC?

ChartMill assigns a fundamental rating of 6 / 10 to HOLX.


Can you provide the valuation status for HOLOGIC INC?

ChartMill assigns a valuation rating of 6 / 10 to HOLOGIC INC (HOLX). This can be considered as Fairly Valued.


How profitable is HOLOGIC INC (HOLX) stock?

HOLOGIC INC (HOLX) has a profitability rating of 7 / 10.


What is the valuation of HOLOGIC INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for HOLOGIC INC (HOLX) is 17.55 and the Price/Book (PB) ratio is 3.31.